Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prioritisation of population groups with the most interactions for COVID-19 vaccination can substantially reduce total fatalities

View ORCID ProfileJorge Rodríguez, Mauricio Patón, Juan M Acuña
doi: https://doi.org/10.1101/2020.10.12.20211094
Jorge Rodríguez
1Department of Chemical Engineering. College of Engineering. Khalifa University. SAN Campus PO Box 2533 Abu Dhabi, United Arab Emirates
2Department of Epidemiology and Public Health. College of Medicine. Khalifa University. PO Box 127788 Abu Dhabi, United Arab Emirates
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jorge Rodríguez
  • For correspondence: jorge.rodriguez@ku.ac.ae
Mauricio Patón
1Department of Chemical Engineering. College of Engineering. Khalifa University. SAN Campus PO Box 2533 Abu Dhabi, United Arab Emirates
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan M Acuña
2Department of Epidemiology and Public Health. College of Medicine. Khalifa University. PO Box 127788 Abu Dhabi, United Arab Emirates
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The rapid development of vaccines against the SARS-CoV-2 virus is an unprecedented achievement. Once vaccines become mass produced, they will have to be distributed to almost the entire population to prevent deaths and permit prompt economic recovery. The necessity to vaccinate a large number of people in a short period of time, and possibly with insufficient vaccine doses to cover most, creates in itself a new challenge for governments and health authorities: which population groups (by age or other criteria) should be targeted first and what sequence must be followed, if any at all, to achieve the minimum number of fatalities? In this work, we demonstrate the importance and impact of optimally planning the priorities for vaccine deployment by population groups using a modified SEIR-type model for the COVID-19 outbreak considering age-related groups. Finding the absolute guaranteed best solution of the mathematical optimisation problem may be hard, if even possible, and would likely require intense computational resources for every possible case study scenario. In this work, several strategies are evaluated and compared, in an attempt to approach the most effective possible vaccination priority sequence in an example case study using demographic and epidemiological data from Spain. The minimum total fatalities at the end of the vaccination campaign is the objective pursued. The population groups classifications are established based on relevant differences in mortality (due to their age) and risk-related behaviour such as their number of daily person-to-person interactions. Assuming a capacity limited constant vaccination rate, vaccination distribution strategies were evaluated for different vaccine effectiveness levels and different percentages of final vaccine population coverage. Our results unambiguously show how planning vaccination by priority groups can achieve dramatic reductions in total fatalities (more than 70% in some cases) compared to no prioritisation. The results also indicate in all cases, for all vaccine effectiveness and coverage values evaluated, that the criteria for groups vaccination priority should not be those with the highest mortality but rather those the highest number of daily person-to-person interactions. Strikingly, our results show in all cases, that prioritisation of groups with the highest mortality but less social interactions, may lead to significantly larger numbers of final total fatalities, even higher as if no group priorities were established at all. The explanation, clearly displayed by the mechanistic model, is that vaccination avoids infections that reduce mortality not only from the vaccinated group itself but also from the projected secondary and subsequent infections inflicted on the rest of the population by those vaccinated in that group. Precisely this amplification effect (exponential nature of the curve) appears to cause the larger reduction in total fatalities if the groups with the most interactions are vaccinated first. The possible contradiction of these results with some published recommendations highlight the importance of conducting an open comprehensive and rigorous analysis of this problem leaving behind any subjective preconceptions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Khalifa University (Grant 8474000317 CRPA-2020-SEHA) and the Government of Abu Dhabi

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The Matlab source code and the Excel files containing all inputs and parameters used are fully available on demand.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted October 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prioritisation of population groups with the most interactions for COVID-19 vaccination can substantially reduce total fatalities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prioritisation of population groups with the most interactions for COVID-19 vaccination can substantially reduce total fatalities
Jorge Rodríguez, Mauricio Patón, Juan M Acuña
medRxiv 2020.10.12.20211094; doi: https://doi.org/10.1101/2020.10.12.20211094
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Prioritisation of population groups with the most interactions for COVID-19 vaccination can substantially reduce total fatalities
Jorge Rodríguez, Mauricio Patón, Juan M Acuña
medRxiv 2020.10.12.20211094; doi: https://doi.org/10.1101/2020.10.12.20211094

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (942)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8969)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1322)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10768)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1818)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4109)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (363)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)